| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC3805 |
| Trial ID | NCT06316427 |
| Disease | T-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD7 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Autologous and Donor-derived CD7 CAR T-cell Therapy in Refractory or Relapsed T-cell Acute Lymphoblastic Leukemia/Lymphoma: a Single-center, Open-label, Phase II Clinical Trial |
| Year | 2024 |
| Country | China |
| Company sponsor | Beijing GoBroad Hospital |
| Other ID(s) | BJGBYY-IIT-LCYJ-2024-003 |
| Cohort 1 | |||||||||
|
|||||||||